Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Alpha Cancer Technologies Inc. logo — HARNESSING NATURE TO BEAT CANCER

Alpha Cancer Technologies Inc.

HARNESSING NATURE TO BEAT CANCER

Founded 2008 Canada Toronto, Canada 5 employees Biotechnology, Pharmaceutical

General Information

Company Name Alpha Cancer Technologies Inc.
Founded Year 2008
Location Canada Toronto, Canada
Employees 5
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Alpha Cancer Technologies Inc.. To contact Alpha Cancer Technologies Inc., visit alpha-cancer.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alpha Cancer Technologies Inc. compare?

A PDF of Alpha Cancer Technologies Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alpha Cancer Technologies Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alpha Cancer Technologies Inc.

Alpha Cancer Technologies Inc. (ACT) is a pioneering entity in the Biotechnology and Pharmaceutical sectors, operating from its headquarters in Canada. Founded in 2008, the company is focused on transformative healthcare solutions with its slogan, "HARNESSING NATURE TO BEAT CANCER."

ACT's core innovation lies in its platform technologies in Immunotherapy and Immuno-Oncology, specifically targeting cancer and auto-immune diseases. The hallmark of their drug development is their proprietary recombinant human alpha fetoprotein (AFP), which has shown promising potential in treating such conditions.

Currently at the private clinical stage, Alpha Cancer Technologies Inc. presents an intriguing opportunity for investors seeking to enter the evolving field of oncological treatments. While the company has yet to disclose its most recent investment and investor details, its strategic focus and niche platform reflect a robust growth potential in a competitive industry landscape.

Business keywords: clinical stage, immunotherapy, immuno-oncology, cancer treatment, drug development, alpha fetoprotein, private company, platform technology, recombinant human AFP, auto-immune diseases, cancer therapy, clinical trials, proprietary technology

No funding data available for Alpha Cancer Technologies Inc. yet.

Alpha Cancer Technologies Inc. Alternatives & Competitors

View All Alternatives
Alpha Cancer Technologies Inc. vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care
Alpha Cancer Technologies Inc. vs
OSE Immunotherapeutics
OSE Immunotherapeutics France

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

Grant
76 employees
Biotechnology, Medical Devices
Alpha Cancer Technologies Inc. vs
Cybrexa Therapeutics
Cybrexa Therapeutics United States

Changing the paradigm for cancer treatment through the development of antigen-independent peptide dr...

Series B
11 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Alpha Cancer Technologies Inc.

HARNESSING NATURE TO BEAT CANCER
Alpha Cancer Technologies Inc. was founded in 2008.
Alpha Cancer Technologies Inc. is headquartered in Toronto, Canada.
Alpha Cancer Technologies Inc. operates in Biotechnology and Pharmaceutical. Its work centres on clinical stage, immunotherapy, immuno-oncology and cancer treatment.
Alpha Cancer Technologies Inc. has approximately 5 employees.
Top alternatives and competitors to Alpha Cancer Technologies Inc. include Apollomics, OSE Immunotherapeutics, Cybrexa Therapeutics, GLG Pharma, Apexigen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alpha Cancer Technologies Inc. and Apollomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alpha Cancer Technologies Inc., https://bouncewatch.com/company/alpha-cancer-technologies, updated 28 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout